1.48
price up icon1.37%   0.02
after-market Dopo l'orario di chiusura: 1.49 0.01 +0.68%
loading
Precedente Chiudi:
$1.46
Aprire:
$1.46
Volume 24 ore:
152.59K
Relative Volume:
0.34
Capitalizzazione di mercato:
$38.66M
Reddito:
$4.75M
Utile/perdita netta:
$-7.83M
Rapporto P/E:
6.7983
EPS:
0.2177
Flusso di cassa netto:
$-7.24M
1 W Prestazione:
-3.27%
1M Prestazione:
-60.63%
6M Prestazione:
-92.06%
1 anno Prestazione:
-49.01%
Intervallo 1D:
Value
$1.41
$1.51
Intervallo di 1 settimana:
Value
$1.29
$1.699
Portata 52W:
Value
$1.29
$99.75

Novabay Pharmaceuticals Inc Stock (NBY) Company Profile

Name
Nome
Novabay Pharmaceuticals Inc
Name
Telefono
510-899-8800
Name
Indirizzo
2000 Powell Street, Suite 1150, Emeryville, CA
Name
Dipendente
86
Name
Cinguettio
@NovaBayPharma
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
NBY's Discussions on Twitter

Compare NBY vs VRTX, REGN, ARGX, ALNY, ONC

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
NBY
Novabay Pharmaceuticals Inc
1.48 38.14M 4.75M -7.83M -7.24M 0.2177
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.82 121.40B 12.07B 3.95B 3.19B 15.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
764.93 83.25B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
728.11 46.39B 4.16B 1.29B 734.26M 19.59
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.51 43.41B 3.71B 313.75M 465.38M 2.2571
Biotechnology icon
ONC
Beone Medicines Ltd Adr
292.94 33.09B 5.36B 287.73M 924.18M 2.5229

Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2019-09-18 Iniziato Ladenburg Thalmann Buy
2018-07-06 Reiterato H.C. Wainwright Buy
2017-11-15 Reiterato Laidlaw Buy
2017-06-05 Iniziato ROTH Capital Buy
2017-03-27 Iniziato Laidlaw Buy
2017-02-06 Iniziato Rodman & Renshaw Buy
2016-03-07 Downgrade Maxim Group Buy → Hold
2015-12-14 Reiterato Maxim Group Buy
2015-04-30 Ripresa Maxim Group Buy
2013-03-06 Iniziato Ascendiant Capital Markets Strong Buy
2008-01-03 Iniziato Dawson James Speculative Buy
Mostra tutto

Novabay Pharmaceuticals Inc Borsa (NBY) Ultime notizie

pulisher
Mar 04, 2026

NBY Earnings History & Surprises | EPS & Revenue Results | NOVABAY PHARMACEUTICALS INC (NYSEARCA:NBY) - ChartMill

Mar 04, 2026
pulisher
Mar 03, 2026

Breakouts Watch: What are the risks of holding NovaBay Pharmaceuticals IncPortfolio Growth Summary & Weekly Market Pulse Updates - baoquankhu1.vn

Mar 03, 2026
pulisher
Mar 02, 2026

Gross margin % of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Mar 02, 2026
pulisher
Feb 28, 2026

NBY SEC FilingsNovabay Pharma 10-K, 10-Q, 8-K Forms - Stock Titan

Feb 28, 2026
pulisher
Feb 26, 2026

Net current asset value per share of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

NovaBay Pharmaceuticals, Inc. Earnings and Revenue – GETTEX:B9P1 - TradingView

Feb 26, 2026
pulisher
Feb 25, 2026

Cash per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Stock Price Passes Below 50-Day Moving AverageHere's What Happened - MarketBeat

Feb 25, 2026
pulisher
Feb 25, 2026

Diluted net income available to common stockholders of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Debt to assets ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Tangible book value per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Net current asset value per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Enterprise value to EBITDA ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Free cash flow per share of NovaBay Pharmaceuticals, Inc. – FWB:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Operating income of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Price to cash flow ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Diluted shares outstanding of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Total revenue of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Free cash flow of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Enterprise value of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Operating expenses (excl. COGS) of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Number of employees of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Gross margin % of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Operating margin % of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Return on invested capital % of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Diluted earnings per share (diluted EPS) of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

EBITDA of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Free cash flow per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

EBITDA per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Total liabilities of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Debt to equity ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Cash from operating activities of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Long term debt to total equity ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

NovaBay Pharmaceuticals, Inc. Earnings and Revenue – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

EBIT of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Operating income of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Average basic shares outstanding of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Total operating expenses of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Net debt of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Total liabilities & shareholders' equities of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Cost of goods sold of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Total equity of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Quick ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

NovaBay Pharmaceuticals, Inc. Cash Flow – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

NovaBay Pharmaceuticals, Inc. Income Statement – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Total debt per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Net margin % of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

NovaBay Pharmaceuticals, Inc. Balance Sheet – MUN:B9P1 - TradingView

Feb 25, 2026
pulisher
Feb 24, 2026

Diluted earnings per share (diluted EPS) of NovaBay Pharmaceuticals, Inc. – FWB:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

NovaBay Pharmaceuticals, Inc. Financial Statements – MUN:B9P1 - TradingView

Feb 24, 2026
pulisher
Feb 24, 2026

NovaBay Pharmaceuticals, Inc. Dividends – MUN:B9P1 - TradingView

Feb 24, 2026

Novabay Pharmaceuticals Inc Azioni (NBY) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$45.68
price down icon 3.69%
$53.83
price down icon 6.87%
$29.72
price up icon 0.68%
$101.95
price down icon 1.78%
$143.57
price down icon 4.21%
biotechnology ONC
$292.94
price down icon 2.03%
Capitalizzazione:     |  Volume (24 ore):